KRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
KORU Medical Systems, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$3.02+0.02 (+0.67%)
Close on Oct 19, 2026
- Market cap
- $149.52M
- P/E (TTM)
- –
- Dividend yield
- –
KORU Medical Systems, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| United States | $30.24M | $27.51M | $23.68M | $23.59M | $19.49M | $20.68M | $19.47M | 73.5% | +9.9% |
| Non-US [Member] | $10.89M | $6.14M | $4.84M | $4.31M | $4.00M | $3.50M | $3.69M | 26.5% | +77.4% |
From the segment and revenue-disaggregation notes of KORU Medical Systems's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.